Executives and directors of UnitedHealth Group were hit with a shareholder derivative suit alleging they concealed that the U.S. Department of Justice reopened an antitrust investigation into the health insurance giant following its acquisition of a healthcare data company and that its brass knowingly sold more than $100 million of shares before the information was publicly revealed.
A copy of the article can be viewed here:
To learn more about this matter, contact us today!
Posted in Uncategorized
